Hemostatic sponge
AssigneesBaxter International Inc., Baxter Healthcare S.A.
InventorsHans Christian Hedrich, Joris Hoefinghoff
Life of this patent
Estimating the term…
Abstract
The present invention provides a hemostatic porous composite sponge comprising i) a matrix of a biomaterial; and ii) one hydrophilic polymeric component comprising reactive groups wherein i) and ii) are associated with each other so that the reactivity of the polymeric component is retained, wherein associated means that said polymeric component is coated onto a surface of said matrix of a biomaterial, or said matrix is impregnated with said polymeric material, or both.
Claims6
1-10. (canceled)
A hemostatic composite comprising a hemostatic material and a single hydrophilic polymeric crosslinker, said crosslinker having electrophilic reactive groups, said composite comprising pores which allow external fluids, especially human blood, to access into said composite, wherein said hemostatic material is a non-woven or woven fabric of a hemostatic fiber.
Dependencies are inferred from the claim text.